| scholarly article | Q13442814 |
| P2093 | author name string | Gennadiy Moiseyev | |
| Jian-Xing Ma | |||
| Zhao Liu | |||
| Rando Allikmets | |||
| Jian Kong | |||
| Kazunori Yamamoto | |||
| Konstantin Petrukhin | |||
| Nicoleta Dobri | |||
| Qiong Qin | |||
| Janet R Sparrow | |||
| P2860 | cites work | Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes | Q24309211 |
| Identification and Characterization of a Non-retinoid Ligand for Retinol-binding Protein 4 Which Lowers Serum Retinol-binding Protein 4 Levels in Vivo | Q27653437 | ||
| A transcriptional co-repressor that interacts with nuclear hormone receptors | Q28289864 | ||
| Impaired retinal function and vitamin A availability in mice lacking retinol-binding protein | Q28509835 | ||
| Alpha-phenyl-N-tert-butylnitrone (PBN) prevents light-induced degeneration of the retina by inhibiting RPE65 protein isomerohydrolase activity | Q28574540 | ||
| A2E, a byproduct of the visual cycle | Q28609934 | ||
| Reductions in Serum Vitamin A Arrest Accumulation of Toxic Retinal Fluorophores: A Potential Therapy for Treatment of Lipofuscin-Based Retinal Diseases | Q29012269 | ||
| Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration. | Q30984629 | ||
| Positively charged retinoids are potent and selective inhibitors of the trans-cis isomerization in the retinoid (visual) cycle | Q33852276 | ||
| Retinoids for treatment of retinal diseases | Q33901076 | ||
| Effects of potent inhibitors of the retinoid cycle on visual function and photoreceptor protection from light damage in mice | Q33931582 | ||
| Safety and effect on rod function of ACU-4429, a novel small-molecule visual cycle modulator. | Q34180463 | ||
| Transcriptional coregulators of the nuclear receptor superfamily: coactivators and corepressors. | Q34209640 | ||
| Classical and novel retinoids: their targets in cancer therapy | Q34605217 | ||
| Fenretinide activates caspases and induces apoptosis in gliomas | Q34876630 | ||
| Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration | Q34960196 | ||
| The coactivator LXXLL nuclear receptor recognition motif. | Q35721024 | ||
| Synthetic retinoids as inducers of apoptosis in ovarian carcinoma cell lines | Q35750446 | ||
| The bisretinoids of retinal pigment epithelium | Q35785390 | ||
| Comparative teratogenicity of nine retinoids in the rat | Q36028706 | ||
| Lipofuscin and N-retinylidene-N-retinylethanolamine (A2E) accumulate in retinal pigment epithelium in absence of light exposure: their origin is 11-cis-retinal | Q36052545 | ||
| Lecithin:retinol acyltransferase is critical for cellular uptake of vitamin A from serum retinol-binding protein | Q36097928 | ||
| RPE lipofuscin and its role in retinal pathobiology | Q36111032 | ||
| New therapeutic targets in atrophic age-related macular degeneration | Q36804427 | ||
| Rpe65 Leu450Met variant is associated with reduced levels of the retinal pigment epithelium lipofuscin fluorophores A2E and iso-A2E. | Q37415751 | ||
| Hemangiosarcoma in rodents: mode-of-action evaluation and human relevance | Q37518959 | ||
| Assay of retinol-binding protein-transthyretin interaction and techniques to identify competing ligands | Q39692377 | ||
| N-(4-hydroxyphenyl)retinamide induces apoptosis in human retinal pigment epithelial cells: retinoic acid receptors regulate apoptosis, reactive oxygen species generation, and the expression of heme oxygenase-1 and Gadd153. | Q40232126 | ||
| beta-Carotene conversion into vitamin A in human retinal pigment epithelial cells | Q40368582 | ||
| Small molecule RPE65 antagonists limit the visual cycle and prevent lipofuscin formation | Q42164095 | ||
| A novel mechanism by which N-(4-hydroxyphenyl)retinamide inhibits breast cancer cell growth: the production of nitric oxide. | Q44248596 | ||
| Fundus autofluorescence and age-related macular degeneration | Q44309998 | ||
| Retinyl esters are the substrate for isomerohydrolase. | Q44318523 | ||
| Retinoid receptor-dependent and independent biological activities of novel fenretinide analogues and metabolites. | Q44615083 | ||
| Sensitivity to DNA damage is a common component of hormone-based strategies for protection of the mammary gland | Q46669847 | ||
| Effects of N-(4-hydroxyphenyl)retinamide on vitamin A metabolism in rats. | Q50921467 | ||
| Cell loss in the aging retina. Relationship to lipofuscin accumulation and macular degeneration. | Q52525243 | ||
| Binding affinities of retinol and related compounds to retinol binding proteins | Q52851433 | ||
| In vitro interaction of fenretinide with plasma retinol-binding protein and its functional consequences | Q67546270 | ||
| Interactions of retinol with binding proteins: implications for the mechanism of uptake by cells | Q68817215 | ||
| Aging human RPE: morphometric analysis of macular, equatorial, and peripheral cells | Q71275163 | ||
| N-(4-hydroxyphenyl)retinamide (fenretinide) induces retinol-binding protein secretion from liver and accumulation in the kidneys in rats | Q72901738 | ||
| Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope | Q73089239 | ||
| Retinol binding protein as a surrogate measure for serum retinol: studies in vitamin A-deficient children from the Republic of the Marshall Islands | Q73585715 | ||
| High-performance liquid chromatography analysis of visual cycle retinoids | Q73758857 | ||
| Retinoid receptor-dependent and -independent effects of N-(4-hydroxyphenyl)retinamide in F9 embryonal carcinoma cells | Q77804745 | ||
| Fenretinide and risk reduction of second breast cancer | Q79680224 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 85-95 | |
| P577 | publication date | 2013-01-07 | |
| P1433 | published in | Investigative Ophthalmology Visual Science | Q6060707 |
| P1476 | title | A1120, a nonretinoid RBP4 antagonist, inhibits formation of cytotoxic bisretinoids in the animal model of enhanced retinal lipofuscinogenesis | |
| P478 | volume | 54 |
| Q89000215 | A non-retinoid antagonist of retinol-binding protein 4 rescues phenotype in a model of Stargardt disease without inhibiting the visual cycle |
| Q36992465 | Bicyclic [3.3.0]-Octahydrocyclopenta[c]pyrrolo Antagonists of Retinol Binding Protein 4: Potential Treatment of Atrophic Age-Related Macular Degeneration and Stargardt Disease |
| Q92915328 | Comparative pharmacokinetics and pharmacodynamics of the advanced Retinol-Binding Protein 4 antagonist in dog and cynomolgus monkey |
| Q38614012 | Complement pathway biomarkers and age-related macular degeneration. |
| Q100455024 | Deep learning segmentation of hyperautofluorescent fleck lesions in Stargardt disease |
| Q91954772 | Design, Synthesis, and Preclinical Efficacy of Novel Nonretinoid Antagonists of Retinol-Binding Protein 4 in the Mouse Model of Hepatic Steatosis |
| Q34243202 | Design, synthesis, and evaluation of nonretinoid retinol binding protein 4 antagonists for the potential treatment of atrophic age-related macular degeneration and Stargardt disease |
| Q38789140 | Dry Age-Related Macular Degeneration Pharmacology |
| Q90437090 | Effects of deficiency in the RLBP1-encoded visual cycle protein CRALBP on visual dysfunction in humans and mice |
| Q98611546 | Engineering AvidCARs for combinatorial antigen recognition and reversible control of CAR function |
| Q33610379 | Inhibitory effects of fenretinide metabolites N-[4-methoxyphenyl]retinamide (MPR) and 4-oxo-N-(4-hydroxyphenyl)retinamide (3-keto-HPR) on fenretinide molecular targets β-carotene oxygenase 1, stearoyl-CoA desaturase 1 and dihydroceramide Δ4-desatura |
| Q37671070 | Inner and outer retinal changes in retinal degenerations associated with ABCA4 mutations |
| Q91830881 | Monitoring and Management of the Patient with Stargardt Disease |
| Q34669685 | Multifunctional PEG retinylamine conjugate provides prolonged protection against retinal degeneration in mice |
| Q28555093 | Norbixin Protects Retinal Pigmented Epithelium Cells and Photoreceptors against A2E-Mediated Phototoxicity In Vitro and In Vivo |
| Q89480128 | Novel bisretinoids of human retina are lyso alkyl ether glycerophosphoethanolamine-bearing A2PE species |
| Q39174655 | Novel therapeutics for Stargardt disease |
| Q34074393 | Pharmacological inhibition of lipofuscin accumulation in the retina as a therapeutic strategy for dry AMD treatment |
| Q37040750 | Photodegradation of retinal bisretinoids in mouse models and implications for macular degeneration |
| Q36067981 | Predicting Progression of ABCA4-Associated Retinal Degenerations Based on Longitudinal Measurements of the Leading Disease Front |
| Q95643265 | Remodeling adipose tissue inflammasome for type 2 diabetes mellitus treatment: Current perspective and translational strategies |
| Q34149638 | Retinal degeneration in animal models with a defective visual cycle |
| Q37462838 | Retinoids and Retinal Diseases |
| Q41440776 | Transgenic Mice Over-Expressing RBP4 Have RBP4-Dependent and Light-Independent Retinal Degeneration |
| Q34366170 | Update on current and future novel therapies for dry age-related macular degeneration |
| Q94400988 | Visual cycle modulators versus placebo or observation for the prevention and treatment of geographic atrophy due to age‐related macular degeneration |
| Q36866107 | Vitamin A-aldehyde adducts: AMD risk and targeted therapeutics |
Search more.